In-House Immunofluorescence Assay for Detection of SARS-CoV-2 Antigens in Cells from Nasopharyngeal Swabs as a Diagnostic Method for COVID-19.

Diagnostics (Basel) · 2021 · PMC8700487 · PMID 34943583

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

As immunofluorescence results depend on the observation of respiratory epithelial cells to identify any SARS-CoV-2-infected cells, the quality of samples including the quantity and type of cells present may contribute to the absence of a clear trend between immunofluorescence and RT-PCR results in Figure 4 .

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.